Building upon these patient-derived genetic data, we have generated the first mouse model of ATC by combining, in the mouse thyroid follicular cells, p53 loss with constitutive PI3K activation, via deletion of the Pten tumor suppressor. Here, TP53 is linked to neoplasm.